Lowsterol-ASP Capsule is a combination pharmaceutical formulation containing Rosuvastatin 10 mg and Aspirin 75 mg, designed for the management of cardiovascular risk factors. Rosuvastatin, a potent HMG-CoA reductase inhibitor, effectively lowers low-density lipoprotein cholesterol (LDL-C) and total cholesterol levels, thereby reducing the risk of atherosclerosis and associated cardiovascular events. Aspirin, an antiplatelet agent, irreversibly inhibits cyclooxygenase-1 (COX-1), leading to decreased thromboxane A2 production and subsequent inhibition of platelet aggregation. This dual-action capsule is indicated for patients requiring both lipid-lowering therapy and antiplatelet prophylaxis, particularly those with a history of coronary artery disease, stroke, or peripheral arterial disease. The combination aids in preventing the progression of atherosclerotic plaques and reduces the incidence of myocardial infarction and ischemic stroke. Lowsterol-ASP should be administered under medical supervision, with regular monitoring of lipid profiles, liver function tests, and bleeding parameters. Caution is advised in patients with active bleeding, hepatic impairment, or hypersensitivity to either component. Adverse effects may include myalgia, gastrointestinal disturbances, and increased bleeding tendency. This combination therapy offers a convenient and effective approach to comprehensive cardiovascular risk management.